Author： Detournay B.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.18, Iss.1, 2000-07, pp. : 83-89
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Economic benefits with enoxaparin sodium in unstable angina
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. :
Access to resources
Recommend
Enoxaparin versus Heparin: The SYNERGY Trial from an Emergency Medicine Perspective
Drugs, Vol. 65, Iss. 10, 2005-01 ,pp. :
Enoxaparin sodium/heparin: Thrombocytopenia: case report
Reactions Weekly, Vol. 1, Iss. 1218, 2008-01 ,pp. :
Enoxaparin sodium superior to heparin for ACS therapy
Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. :
Enoxaparin sodium/heparin: Heparin-induced thrombocytopenia: case report
Reactions Weekly, Vol. 1, Iss. 1323, 2010-01 ,pp. :